Literature DB >> 31653758

Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast.

Marijn A Vermeulen1, Carolien Hm van Deurzen2,3, Carolien P Schroder3,4, John Wm Martens3,5, Paul J van Diest6.   

Abstract

AIMS: The aim of this study was to determine the role of hypoxia in male breast carcinogenesis by evaluating the expression of the hypoxia-related proteins, hypoxia-inducible factor-1α (HIF-1α), carbonic anhydrase IX (CAIX) and glucose transporter-1 (Glut-1), in ductal carcinoma in situ (DCIS) of the male breast in relation to invasive cancer (IC).
METHODS: Tumour tissue blocks of 18 cases of pure DCIS, 58 DCIS cases adjacent to IC (DCIS-AIC) and the 58 IC cases were stained by immunohistochemistry for HIF-1α, CAIX and Glut-1, and expression frequencies and patterns (diffuse and/or perinecrotic) were noted.
RESULTS: HIF-1α overexpression was observed in 61.1% (11/18) of pure DCIS, in 37.9% (22/58) of DCIS-AIC and in 36.2% (21/58) of IC cases (not significant (n.s.)). CAIX overexpression was observed in 16.7% (3/18) of pure DCIS, in 37.9% (22/58) of DCIS-AIC and in 24.1% (14/58) of IC cases (n.s.). Glut-1 overexpression was observed in 61.1% (11/18) of pure DCIS, in 75.9% (44/58) of DCIS-AIC and in 62.1% (36/58) of IC cases (n.s.). Expression of hypoxia-related proteins was seen around necrosis in a little over one-third of DCIS cases, and often coincided with expression in adjacent IC when present. All these observations indicate that the hypoxia response is already at its maximum in the preinvasive DCIS stage.
CONCLUSIONS: In conclusion, male DCIS frequently shows activated hypoxia response, comparable to male IC. This indicates that the activated hypoxia response previously seen in male IC is not a late bystander but likely a genuine carcinogenetic event. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  breast cancer; ductal carcinoma in situ; hypoxia; male

Year:  2019        PMID: 31653758     DOI: 10.1136/jclinpath-2019-206116

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  2 in total

1.  Down-Regulation of Hypoxia-Inducible Factor-1α and Downstream Glucose Transporter Protein-1 Gene by β-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.

Authors:  Wenbo Wu; Zhonghui Hu; Qingtao Zhao; Xiaopeng Zhang; Hua Zhang; Huien Wang; Wenfei Xue; Lei Yu; Guochen Duan
Journal:  Onco Targets Ther       Date:  2020-11-13       Impact factor: 4.147

2.  Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression.

Authors:  Yvonne E Smith; Guannan Wang; Ciara L Flynn; Stephen F Madden; Owen MacEneaney; Rodrigo G B Cruz; Cathy E Richards; Hanne Jahns; Marian Brennan; Mattia Cremona; Bryan T Hennessy; Katherine Sheehan; Alexander Casucci; Faizah A Sani; Lance Hudson; Joanna Fay; Sri H Vellanki; Siobhan O'Flaherty; Marc Devocelle; Arnold D K Hill; Kieran Brennan; Saraswati Sukumar; Ann M Hopkins
Journal:  Cancers (Basel)       Date:  2022-03-03       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.